Goal To Improve Patient Outcomes Through Early, Accurate Detection Of Residual Or Recurring Cancer Haystack’s Highly Sensitive Minimal-Residual Disease…
BioMADE Funding To Accelerate Capra Bioreactor Expansion and Technical Advancement, Aligning with New White House Bioeconomy Goals MANASSAS, Va., April…
GERMANTOWN, Md., April 25, 2023 (Newswire.com) - Seraxis Inc., a pre-clinical stage company with a best-in-class islet replacement therapy for insulin-dependent…
Emmes collaborates with pharmaceutical companies as strategic partners, providing one-stop clinical trial services, reducing costs, and accelerating development. SAN ANTONIO,…